barriers include national institutes health funding experiments use genome editing technologies human embryos experiment crispr alter dna human embryos 2015 embryos obtained fertility clinics genetic defects never developed new work technology review reported mitalipov colleagues created human embryos sperm donated men genetic mutation planned try repair crispr embryos described clinical quality 2017 china crispr edit dna normal presumably viable fertilized eggs cell human embryos contrast experiments china led mitalipov reportedly produced effects editing genes crispr supposed leave experiment avoided called mosaicism cells embryo intended dna changes embryos not allowed develop early stage changing dna early embryo results changes cells eventually